Information Provided By: 
Fly News Breaks for January 2, 2020
AVTR
Jan 2, 2020 | 07:33 EDT
RBC Capital analyst Anton Hie keeps his Outperform rating and $22 price target on Avantor ahead of its Q4 results, saying the company is heading for a "strong performance" with "solid" momentum after a miss in Q3, particularly in its Biopharma business. The analyst is citing the recent commentary from Avantor management which suggest that the Q3 miss was an "aberration" and that the underlying fundamentals of its business remain strong.
News For AVTR From the Last 2 Days
